ClinicalTrials.Veeva

Menu

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Indiana University logo

Indiana University

Status

Enrolling

Conditions

Small Cell Lung Cancer

Treatments

Procedure: Biospecimen Collection

Study type

Observational

Funder types

Other

Identifiers

NCT05889546
CTO-IUSCCC-0783

Details and patient eligibility

About

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Full description

The goal of this project to establish a rapid autopsy program in SCLC at the IUSCCC and outline the key components necessary for tumor tissue acquisition. This proposal is a collaboration between scientists, lung cancer physicians, pathologists, and the IUSCCC Translational Research Core. Tumor tissue collected will be used for protein and gene analysis and RNA, whole exome sequencing in addition to the establishment of SCLC. This research is part of a discovery project in which biological and molecular markers of SCLC will be identified.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. ≥ 18 years old at the time of informed consent
  2. Written informed consent and HIPAA authorization for release of personal health information.
  3. Active SCLC diagnosis.

Trial design

30 participants in 1 patient group

Active SCLC Diagnosis
Treatment:
Procedure: Biospecimen Collection

Trial contacts and locations

3

Loading...

Central trial contact

Gabby Kline, BA; Shadia I. Jalal, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems